Company Details
Sector | PHARMACEUTICALS |
Address | 35 - Dockyard Road West Wharf Karachi |
Auditor | Yousuf Adil, Chartered Accountants |
Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
Website | www.pk.gsk.com |
Fiscal Year | December |
Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
Date/Time | Announcement |
---|---|
22/08/2014 15:11:37 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 792.670 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2014 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,303.182 EPS = 2.49 |
28/04/2014 11:57:36 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2014 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 797.948 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 484.848 EPS = 1.67 |
07/02/2014 15:24:14 | FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2013 DIVIDEND = 35% BONUS ISSUE = 10% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,809.872 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,062.263 EPS = 3.67 ANNUAL GENERAL MEETING WILL BE HELD ON 28/04/2014 BOOK CLOSURE FROM 21/04/2014 BOOK CLOSURE TO 28/04/2014 |
28/10/2013 13:53:36 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2013 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,484.382 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 854.382 EPS = 2.95 |
23/08/2013 14:31:06 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 713.682 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,270.682 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2013 EPS = 2.47 |